Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation

Sci Rep
6 April 2017
https://pubmed.ncbi.nlm.nih.gov/28386103/

Naltrexone at low doses (LDN) and its relevance to cancer therapy

Expert Rev Anticancer Ther
02 Feb 2022
https://pubmed.ncbi.nlm.nih.gov/35107043/

New research gives hope to COVID-19 long haul carriers

Ohio News Time
January 2022
https://ohionewstime.com/new-research-gives-hope-to-covid-19-long-haul-carriers/323883/

Burton Berkson, MD, MS, PhD - Cancers and Autoimmune Disease (2013 Conference) (LDN, low dose naltrexone)

Deanna Windham, DO - LDN in Allergies, Autoimmune Disease and Pediatrics (2013 Conference) (LDN, low dose naltrexone)

Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Low-dose Naltrexone for atopic dermatitis?

National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/

Dr Armin Schwarzbach - Lyme Disease (2014 Conference) (LDN, low dose naltrexone)